Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

TWH Flinsenberg; CC Tromedjo; N Hu; Y Liu; Y Guo; KYT Thia; T Noori; X Song; HXA Yeang; DG Tantalo; S Handunnetti; JF Seymour; AW Roberts; D Ritchie; R Koldej; PJ Neeson; L Wang; JA Trapani; CS Tam; I Voskoboinik

Journal article

Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

TWH Flinsenberg, CC Tromedjo, N Hu, Y Liu, Y Guo, KYT Thia, T Noori, X Song, HXA Yeang, DG Tantalo, S Handunnetti, JF Seymour, AW Roberts, D Ritchie, R Koldej, PJ Neeson, L Wang, JA Trapani, CS Tam, I Voskoboinik

Haematologica | FERRATA STORTI FOUNDATION | Published : 2020

DOI: 10.3324/haematol.2019.220590

University of Melbourne Researchers

Han Aw Yeang Author

John Seymour Author

Andrew Roberts Author

David Ritchie Author

Grants

Awarded by European Molecular Biology Organization

Funding Acknowledgements

we acknowledge the support of EMBO (ALTF 219-2017 for TF), CLL Global Research Foundation for CT and IV, National Health and Medical Research Council for IV and JT.